Gerresheimer Strengthens Business in Russia

DUSSELDORF, Germany, April 7, 2010 -

    - Representative office in Moscow opened
    - New support base intensifies marketing and sales
    - Russia's pharma market growing dynamically

Gerresheimer AG has set up a sales office in Moscow. The new
representation centre will intensify the Group's business in pharmaceutical
primary packaging and drug-delivery systems. "This is a strategically
important step to further develop the fast-growing pharma & healthcare
markets of Russia and neighboring regions," says Gerresheimer CEO Dr. Axel
Herberg.

The Duesseldorf Group, which has been active in Russia for
many years, has numerous customers there. For example the Group supplies the
Moscow company Petrovax Pharm with large quantities of pre-sterilized RTF(R)
(Ready To Fill) syringes for vaccines. The business in high-quality pharma
vials and ampoules is also well established.

Regional representation will contribute to intensification not
only of sales operations but also customer advice and technical service on
the spot. In general, the Russian pharma industry has a strong interest in
developing its quality and technologies together with competent partners.

This fast-growing pharma & healthcare market is seen as
extremely dynamic and offers Gerresheimer good growth opportunities.

About Gerresheimer

Gerresheimer is an internationally leading manufacturer of
high-quality specialty products made of glass and plastic for the global
pharma & healthcare industry. Our wide product spectrum ranges from
pharmaceutical vials to complex drug delivery systems, such as syringe
systems, insulin pens and inhalers, for safe dosage and application.
Together with our partners we develop solutions which set standards and have
role-model status throughout their respective business sectors.

Our Group of companies achieves in Europe, North and South
America and Asia sales of about EUR1 billion and employs around 9,400 people.
Through top-class technologies, convincing innovations and targeted
investments we are systematically expanding our strong market position.

    Press Contact
    Burkhard Lingenberg
    Director Corporate Communication & Marketing Director
    Phone +49-211-6181-250
    Fax +49-211-6181-241
    e-mail b.lingenberg@gerresheimer.com 

    Investor Relations Contact
    Anke Linnartz
    Corporate Investor Relations
    Phone +49-211-6181-314
    Fax +49-211-6181-121
    email a.linnartz@gerresheimer.com

Contact Press: Burkhard Lingenberg, Director Corporate Communication & Marketing, Phone +49-211-6181-250, Fax +49-211-6181-241, e-mail b.lingenberg at gerresheimer.com ; Investor Relations: Anke Linnartz, Corporate Investor Relations, Phone +49-211-6181-314, Fax +49-211-6181-121, email a.linnartz at gerresheimer.com